Adhansia XR Labeling Updated With Additional Clinical Data
The sNDA approval was based on data from a phase 3 Adult Laboratory Classroom study that assessed the efficacy and safety of Adhansia XR in adults diagnosed with ADHD.
The sNDA approval was based on data from a phase 3 Adult Laboratory Classroom study that assessed the efficacy and safety of Adhansia XR in adults diagnosed with ADHD.
There have not been very many studies which examined the association between secondhand smoke and ADHD symptoms in children. Thus, the researchers sought to evaluate whether or not there is a relationship between the two.
This genome-wide associated study expanded on the gene-environment correlation for childhood maltreatment and causal relationship between childhood maltreatment and health.
Qelbree is a selective norepinephrine reuptake inhibitor.
Researchers in Italy surveyed parents of adolescents and children with ADHD to assess changes in sleep-wake patterns due to the COVID-19 lockdown.
Although sleep disorders are often difficult to treat, increased knowledge regarding the disordered sleep associated with ASD could lead to effective treatments for these patients.
Practicing mindfulness exercising using the Headspace app improved inattentiveness and hyperactive/impulsivity scores in children and teens with ADHD.
Among adults without a clinical diagnosis of ADHD, heavy alcohol use predicted more severe ADHD symptoms.
The FDA has cleared EndeavorRxTM (AKL-T01; Akili Interactive) for use as a prescription-only video game-based digital therapeutic to improve attention function in pediatric patients aged 8-12 years with primarily inattentive or combined-type ADHD.
For children with ADHD, parents reported worsened ADHD behaviors during the COVID-19 outbreak, with children’s and parents’ moods positively associated with behavior.